Offer - Urjas Oil for just ₹ 1 X
Myoril 4 Mg Capsule is a prescription medicine that is available as a Capsule. It is typically used for the treatment of Muscle Spasms. The alternative uses of Myoril 4 Mg Capsule have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Myoril 4 Mg Capsule. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Myoril 4 Mg Capsule have been listed ahead. These side effects of Myoril 4 Mg Capsule are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Myoril 4 Mg Capsule's effect during pregnancy is Severe and Moderate while nursing. It is important to know if Myoril 4 Mg Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Myoril 4 Mg Capsule related warnings section.
Some other conditions that can be affected by Myoril 4 Mg Capsule are listed in the contraindications section below.
Besides this, Myoril 4 Mg Capsule may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Myoril 4 Mg Capsule is considered not safe while driving, and is not addictive.
Myoril 4 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Myoril 4 Mg Capsule safe for pregnant women?
Myoril shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Myoril 4 Mg Capsule safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Myoril. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Myoril 4 Mg Capsule on the Kidneys?
There can be some harmful effects on your kidneys after taking Myoril. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Myoril 4 Mg Capsule on the Liver?
The liver can be affected by Myoril. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Myoril only after medical advice.
What is the effect of Myoril 4 Mg Capsule on the Heart?
Very few cases of side effects of Myoril on the heart have been reported.
Myoril 4 Mg Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Myoril 4 Mg Capsule unless your doctor advises you to do so -
Is this Myoril 4 Mg Capsule habit forming or addictive?
Myoril 4 Mg Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Myoril 4 Mg Capsule as you may feel sleepy.
Is it safe?
Yes, but take Myoril 4 Mg Capsule only as per medical advice.
Is it able to treat mental disorders?
No, the use of Myoril 4 Mg Capsule in mental disorders is not effective.
Interaction between Food and Myoril 4 Mg Capsule
There isn't any research available on the side effects of taking Myoril 4 Mg Capsule with food.
Interaction between Alcohol and Myoril 4 Mg Capsule
Consuming Myoril 4 Mg Capsule with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 358